2001 AUG 16 - (NewsRx.com & NewsRx.net) --
by Sonia Nichols, senior medical writer - Between 1993 and 1994, 25 patients in the United Kingdom with severe immune system deficiencies were inadvertently infected with hepatitis C virus (HCV) when treated with a contaminated batch of immunoglobulin. Investigators recently released a follow-up report of those 25 individuals in the journal Clinical Immunology.
All 25 patients, affected by primary antibody deficiencies, received intravenous administrations from the same batch of contaminated immunoglobulin, according to H.M. Chapel and colleagues, John Radcliffe Hospital, Oxford, England.
"Of these …
Комментариев нет:
Отправить комментарий